PulseAGGREGATOR

Home Feed Stories Sources Features

PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

Legal

Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate | Pulse Aggregator

← Back to feed

Cision PR Newswire APAC

pressCenter

1h ago

Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugatetranslating…

FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development ALAMEDA, Calif. and TAIPEI, Sept. 4, 2026 /PRNewswire/ -- Acepodia (6976: TT), a clinical-stage biotechnology company developing next-generation…

Factuality

84/100

Political Bias

Center

Ownership

Cision Communications

Country

Unknown

Keywords#FDA Clearance#Acepodia#ACE723#Acepodia Announces#Acepodia Announces FDA

Read Original ↗ Article view

Comments

Loading comments…